Product Search

  • Type 2 Diabetes in Brazil
    Emerging Markets, July, 2014

    In 2013, Brazil’s total pharmaceutical market for type 2 diabetes rivaled the size of some of the major markets. Increasing public awareness, an aging...

  • Prostate Cancer in China
    Emerging Markets, December, 2013

    China will see a great increase in the number of diagnosed incident cases of prostate cancer over the next decade, with most growth in the urban setting....

  • Non-Small-Cell Lung Cancer in Argentina, Brazil, and Mexico
    Emerging Markets, November, 2013

    The combined NSCLC market of Argentina, Brazil, and Mexico will grow at a rate of 6% per year between 2013 and 2018, and the number of NSCLC incident cases...

  • Acute Coronary Syndrome in Russia
    Emerging Markets, October, 2013

    In Russia, as in Western markets, polypharmacy plays a critical role in the management of patients with acute coronary syndrome (ACS), a factor which has led...

  • Colorectal Cancer in Turkey
    Emerging Markets, August, 2013

    The Turkish CRC market
    will grow at 4% annually between 2012-2017 and the number of CRC incident cases
    will almost double between 2012-2022. Growing...

  • Type 2 Diabetes in China
    Emerging Markets, August, 2013

    Based on the diagnostic criteria
    developed in 1999 by the World Health Organization, China has the largest
    prevalent population of type 2 diabetes in...

  • Non-Small-Cell Lung Cancer in Turkey
    Emerging Markets, June, 2013

    The Turkish NSCLC market will grow at a rate of 7% per year between 2012 and 2017, and the number of NSCLC incident cases will grow by nearly 30% between 2012...

  • Hepatitis C Virus in Turkey
    Emerging Markets, May, 2013

    The Turkish government has heavily invested in healthcare over the past two decades, which results in sustained growth in the Turkish pharmaceutical market....

  • Breast Cancer in the BRIC Markets
    Emerging Markets, December, 2012

    Over the next nine years, the diagnosed incidence of CaB in the BRIC (Brazil, Russia, India and China) will grow at almost three times the average annual...

  • Breast Cancer in Mexico
    Emerging Markets, November, 2012

    Over the next decade, the diagnosed  incidence of breast cancer (CaB) in Mexico will increase at almost three times the average annual growth rate in the major...

  • Atrial Fibrillation in Brazil
    Emerging Markets, November, 2012

    Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The disease represents an area of significant unmet need in...

  • Atrial Fibrillation in China
    Emerging Markets, November, 2012

    Atrial fibrillation (AF) is the most common cardiac arrhythmia encountered in clinical practice. The disease continues to represent an area of significant...

  • Type 2 Diabetes in South Korea
    Emerging Markets, October, 2012

    South Korea has one of the most advanced healthcare systems in the world and a rapidly expanding pharmaceutical market. Combined with increasing awareness of...

  • Prostate Cancer in Russia
    Emerging Markets, September, 2012

    The incidence of prostate cancer (CaP) in Russia is the second highest among the BRIC countries (Brazil, Russia, India, China). Russia will experience a...

  • TRAINING VIDEO: Decision Resources Group Emerging Markets Coverage
    Training and Support Materials, August, 2012

    View a brief walk-through of DRG’s coverage of emerging and growth markets.

    August 2012 —

  • Non-Small-Cell Lung Cancer in China
    Emerging Markets, July, 2012

    China is one of the most rapidly growing pharmaceutical markets in the world, and it has a vast, rapidly expanding prevalent population of non-small-cell lung...

  • Colorectal Cancer in Russia
    Emerging Markets, May, 2012

    The incidence of colorectal cancer (CRC) in Russia is the highest among the BRIC (Brazil, Russia, India, China) markets and is comparable to that of the United...

  • Colorectal Cancer in China
    Emerging Markets, March, 2012

    China has one of the most rapidly growing pharmaceutical markets in the world, as well as a vast, rapidly expanding prevalent population of colorectal cancer...

  • Non-Small-Cell Lung Cancer in Russia
    Emerging Markets, December, 2011

    The incidence of non-small-cell lung cancer (NSCLC) in Russia is the highest among the BRIC (Brazil, Russia, India, China) markets, and is comparable to that...

  • Acute Coronary Syndrome in Brazil
    Emerging Markets, November, 2011

    Acute coronary syndrome (ACS)—an umbrella term that encompasses acute ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction...

Displaying results 1-20 (of 74)
 |<  < 1 2 3 4  >  >| 

Search Reports

Decision Resources Group brands include: